rxstat › Shortages › Tadalafil
Tadalafil shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Tadalafil products are in shortage in Canada (2 of 45 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 19, 2026.
In shortage since
Nov 30, 2017
Est. full return
Jun 19, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-TADALAFIL
20MG · TABLET · SUN PHARMA CANADA INC
DIN 02452111 · since Apr 16, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Active shortageMAR-TADALAFIL
2.5MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02452286 · since Nov 30, 2017, no end estimate · Delay in shipping of the drug.
DiscontinuedADCIRCA
20MG · TABLET · ELI LILLY CANADA INC
DIN 02338327
ResolvedMYLAN-TADALAFIL
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410656 · ended Feb 6, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-TADALAFIL
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02452073 · ended Jan 14, 2026 · Other (Please describe in comments)
ResolvedMYLAN-TADALAFIL
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410664 · ended Oct 2, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-TADALAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410648 · ended Sep 29, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-TADALAFIL
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410656 · ended Sep 29, 2025 · Disruption of the manufacture of the drug.
ResolvedTADALAFIL
10MG · TABLET · SANIS HEALTH INC
DIN 02457024 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
ResolvedTADALAFIL
5MG · TABLET · SANIS HEALTH INC
DIN 02457016 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
ResolvedTADALAFIL
20MG · TABLET · SANIS HEALTH INC
DIN 02457032 · ended Sep 25, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-TADALAFIL
5MG · TABLET · TEVA CANADA LIMITED
DIN 02440156 · ended Jun 12, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Tadalafil is currently affected by 2 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, MARCAN PHARMACEUTICALS INC.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Tadalafil is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BE).
Recent changes
Common questions
When will Tadalafil be back in stock in Canada?
The latest manufacturer estimate is Jun 19, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Tadalafil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.